Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/amlodipine versus amlodipine alone in uncontrolled essential hypertension
2004-000677-62Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Valsartan + amlodipine with Amlodipine alone (2 arms). Primary endpoint: Change in mean sitting diastolic blood pressure from baseline to 8 weeks. Started Aug 2004; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2004-000677-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000677-62.